Skip to main content
Top
Published in: Dysphagia 1/2023

Open Access 18-06-2022 | Esophageal Cancer | Original Article

Effect of Postoperative Oral Intake Status on Sarcopenia Six Months After Esophageal Cancer Surgery

Authors: Nanako Hijikata, Aiko Ishikawa, Satoru Matsuda, Michiyuki Kawakami, Kaori Muraoka, Makiko Ando, Shuhei Mayanagi, Tomoyuki Irino, Hirofumi Kawakubo, Yuko Kitagawa, Tetsuya Tsuji

Published in: Dysphagia | Issue 1/2023

Login to get access

Abstract

Purpose

In patients with esophageal cancer, skeletal muscle mass has been reported to decrease progressively after surgery and be independently associated with a poor prognosis. The purpose of this study was to investigate perioperative changes in dysphagia, oral intake status, and nutritional status and identify factors related to sarcopenia 6 months after esophagectomy.

Methods

A total of 134 patients who underwent radical resection for thoracic esophageal cancer between March 2016 and July 2019 were analyzed retrospectively. The diagnosis of sarcopenia was made by CT taken 6 months postoperatively using the cut-off criteria of skeletal muscle index (SMI) < 52.4 cm2/m2 for male and SMI < 38.5 cm2/m2 for female patients. As factors related to postoperative sarcopenia, dysphagia, oral intake status, nutritional status, and physical function were extracted from the medical records. Multivariate logistic regression analysis was performed to identify perioperative risk factors related to sarcopenia 6 months after surgery.

Results

Of the 134 patients, 34.3% were judged to be unable to start oral intake on swallowing assessment. At discharge, 30.6% received tube feeding with or without oral intake. In the non-oral intake group on swallowing assessment, a significantly higher proportion of patients received tube feeding at discharge (p = 0.014). Preoperative BMI, postoperative handgrip strength, and tube feeding at discharge were independent risk factors for sarcopenia 6 months after esophagectomy in male patients.

Conclusion

Tube feeding at discharge is significantly related to postoperative sarcopenia in patients with esophageal cancer. Identifying high-risk groups might allow early detection of malnutrition and provision of appropriate care.
Appendix
Available only for authorised users
Literature
1.
go back to reference Janssen I. The epidemiology of sarcopenia. Clin Geriatr Med. 2011;27(3):355–63. Janssen I. The epidemiology of sarcopenia. Clin Geriatr Med. 2011;27(3):355–63.
2.
go back to reference Muscaritoli M, Anker SD, Argilés J, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by special interest groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics.” Clin Nutr. 2010;29(2):154–9. Muscaritoli M, Anker SD, Argilés J, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by special interest groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics.” Clin Nutr. 2010;29(2):154–9.
3.
go back to reference Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on Sarcopenia in older people. Age Ageing. 2010;39(4):412–23. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on Sarcopenia in older people. Age Ageing. 2010;39(4):412–23.
4.
go back to reference Steenhagen E, van Vulpen JK, van Hillegersberg R, et al. Nutrition in peri-operative esophageal cancer management. Expert Rev Gastroenterol Hepatol. 2017;11(7):663–72. Steenhagen E, van Vulpen JK, van Hillegersberg R, et al. Nutrition in peri-operative esophageal cancer management. Expert Rev Gastroenterol Hepatol. 2017;11(7):663–72.
5.
go back to reference Peterson SJ, Mozer M. Differentiating Sarcopenia and cachexia among patients with cancer. Nutr Clin Pract. 2017;32(1):30–9. Peterson SJ, Mozer M. Differentiating Sarcopenia and cachexia among patients with cancer. Nutr Clin Pract. 2017;32(1):30–9.
6.
go back to reference Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31. Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31.
7.
go back to reference Chen LK, Woo J, Assantachai P, et al. Asian working group for Sarcopenia: 2019 consensus update on Sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020;21(3):300–7. Chen LK, Woo J, Assantachai P, et al. Asian working group for Sarcopenia: 2019 consensus update on Sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020;21(3):300–7.
8.
go back to reference Fearon K, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: an international consensus framework. Lancet Oncol. 2010;12:489–95. Fearon K, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: an international consensus framework. Lancet Oncol. 2010;12:489–95.
9.
go back to reference Hilmi M, Jouinot A, Burns R, et al. Body composition and sarcopenia: the next-generation of personalized oncology and pharmacology? Pharmacol Ther. 2019;196:135–59. Hilmi M, Jouinot A, Burns R, et al. Body composition and sarcopenia: the next-generation of personalized oncology and pharmacology? Pharmacol Ther. 2019;196:135–59.
12.
go back to reference Elliott JA, Doyle SL, Murphy CF, et al. Sarcopenia: prevalence, and impact on operative and oncologic outcomes in the multimodal management of locally advanced esophageal cancer. Ann Surg. 2017;266(5):822–30. Elliott JA, Doyle SL, Murphy CF, et al. Sarcopenia: prevalence, and impact on operative and oncologic outcomes in the multimodal management of locally advanced esophageal cancer. Ann Surg. 2017;266(5):822–30.
13.
go back to reference Mayanagi S, Tsubosa Y, Omae K, et al. Negative impact of skeletal muscle wasting after neoadjuvant chemotherapy followed by surgery on survival for patients with thoracic esophageal cancer. Ann Surg Oncol. 2017;24(12):3741–7. Mayanagi S, Tsubosa Y, Omae K, et al. Negative impact of skeletal muscle wasting after neoadjuvant chemotherapy followed by surgery on survival for patients with thoracic esophageal cancer. Ann Surg Oncol. 2017;24(12):3741–7.
14.
go back to reference Takahashi K, Watanabe M, Kozuki R, et al. Prognostic significance of skeletal muscle loss during early postoperative period in elderly patients with esophageal cancer. Ann Surg Oncol. 2019;26(11):3727–35. Takahashi K, Watanabe M, Kozuki R, et al. Prognostic significance of skeletal muscle loss during early postoperative period in elderly patients with esophageal cancer. Ann Surg Oncol. 2019;26(11):3727–35.
15.
go back to reference Nakashima Y, Saeki H, Hu Q, et al. Skeletal muscle loss after esophagectomy is an independent risk factor for patients with esophageal cancer. Ann Surg Oncol. 2020;27(2):492–8. Nakashima Y, Saeki H, Hu Q, et al. Skeletal muscle loss after esophagectomy is an independent risk factor for patients with esophageal cancer. Ann Surg Oncol. 2020;27(2):492–8.
16.
go back to reference Anandavadivelan P, Lagergren P. Cachexia in patients with oesophageal cancer. Nat Rev Clin Oncol. 2016;13(3):185–98. Anandavadivelan P, Lagergren P. Cachexia in patients with oesophageal cancer. Nat Rev Clin Oncol. 2016;13(3):185–98.
17.
go back to reference Martin L, Jia C, Rouvelas I, et al. Risk factors for malnutrition after oesophageal and cardia cancer surgery. Br J Surg. 2008;95(11):1362–8. Martin L, Jia C, Rouvelas I, et al. Risk factors for malnutrition after oesophageal and cardia cancer surgery. Br J Surg. 2008;95(11):1362–8.
18.
go back to reference Martin L, Lagergren P. Risk factors for weight loss among patients surviving 5 years after esophageal cancer surgery. Ann Surg Oncol. 2015;22(2):610–6. Martin L, Lagergren P. Risk factors for weight loss among patients surviving 5 years after esophageal cancer surgery. Ann Surg Oncol. 2015;22(2):610–6.
19.
go back to reference Gannon JA, Guinan EM, Doyle SL, et al. Reduced fitness and physical functioning are long-term sequelae after curative treatment for esophageal cancer: a matched control study. Dis Esophagus. 2017;30(8):1–7. Gannon JA, Guinan EM, Doyle SL, et al. Reduced fitness and physical functioning are long-term sequelae after curative treatment for esophageal cancer: a matched control study. Dis Esophagus. 2017;30(8):1–7.
20.
go back to reference Kaburagi T, Takeuchi H, Kawakubo H, et al. Clinical utility of a novel hybrid position combining the left lateral decubitus and prone positions during thoracoscopic esophagectomy. World J Surg. 2014;38(2):410–8. Kaburagi T, Takeuchi H, Kawakubo H, et al. Clinical utility of a novel hybrid position combining the left lateral decubitus and prone positions during thoracoscopic esophagectomy. World J Surg. 2014;38(2):410–8.
21.
go back to reference Takeuchi M, Kawakubo H, Mayanagi S, et al. Influence of neoadjuvant therapy on poor long-term outcomes of postoperative complications in patients with esophageal squamous cell carcinoma: a retrospective cohort study. Ann Surg Oncol. 2019;26(7):2081–9. Takeuchi M, Kawakubo H, Mayanagi S, et al. Influence of neoadjuvant therapy on poor long-term outcomes of postoperative complications in patients with esophageal squamous cell carcinoma: a retrospective cohort study. Ann Surg Oncol. 2019;26(7):2081–9.
22.
go back to reference Matsuda S, Kawakubo H, Takeuchi H, et al. Minimally invasive oesophagectomy with extended lymph node dissection and thoracic duct resection for early-stage oesophageal squamous cell carcinoma. Br J Surg. 2020;107(6):705–11. Matsuda S, Kawakubo H, Takeuchi H, et al. Minimally invasive oesophagectomy with extended lymph node dissection and thoracic duct resection for early-stage oesophageal squamous cell carcinoma. Br J Surg. 2020;107(6):705–11.
23.
go back to reference Rosenbek JC, Robbins JA, Roecker EB, et al. A penetration-aspiration scale. Dysphagia. 1996;11(2):93–8. Rosenbek JC, Robbins JA, Roecker EB, et al. A penetration-aspiration scale. Dysphagia. 1996;11(2):93–8.
24.
go back to reference Kight CE. Nutrition considerations in esophagectomy patients. Nutr Clin Pract. 2008;23(5):521–8. Kight CE. Nutrition considerations in esophagectomy patients. Nutr Clin Pract. 2008;23(5):521–8.
25.
go back to reference Prado CM, Lieffers JR, McCargar LJ, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008;9(7):629–35. Prado CM, Lieffers JR, McCargar LJ, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008;9(7):629–35.
26.
go back to reference Tamandl D, Paireder M, Asari R, et al. Markers of sarcopenia quantified by computed tomography predict adverse long-term outcome in patients with resected oesophageal or gastro-oesophageal junction cancer. Eur Radiol. 2016;26(5):1359–67. Tamandl D, Paireder M, Asari R, et al. Markers of sarcopenia quantified by computed tomography predict adverse long-term outcome in patients with resected oesophageal or gastro-oesophageal junction cancer. Eur Radiol. 2016;26(5):1359–67.
27.
go back to reference Sobin LHGM, Wittekind C. TNM classification of malignant tumors. 7th ed. Oxford: Wiley-Blackwell; 2010. Sobin LHGM, Wittekind C. TNM classification of malignant tumors. 7th ed. Oxford: Wiley-Blackwell; 2010.
28.
go back to reference Onodera T, Goseki N, Kosaki G. Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. J Jpn Surg Soc. 1984;85:1001–5. Onodera T, Goseki N, Kosaki G. Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. J Jpn Surg Soc. 1984;85:1001–5.
29.
go back to reference Kunieda K, Ohno T, Fujishima I, et al. Reliability and validity of a tool to measure the severity of dysphagia: the food intake level scale. J Pain Symptom Manage. 2013;46(2):201–6. Kunieda K, Ohno T, Fujishima I, et al. Reliability and validity of a tool to measure the severity of dysphagia: the food intake level scale. J Pain Symptom Manage. 2013;46(2):201–6.
30.
go back to reference Yoshimura Y, Wakabayashi H, Bise T, et al. Prevalence of sarcopenia and its association with activities of daily living and dysphagia in convalescent rehabilitation ward inpatients. Clin Nutr. 2018;37(6):2022–8. Yoshimura Y, Wakabayashi H, Bise T, et al. Prevalence of sarcopenia and its association with activities of daily living and dysphagia in convalescent rehabilitation ward inpatients. Clin Nutr. 2018;37(6):2022–8.
31.
go back to reference Su H, Ruan J, Chen T, et al. CT-assessed Sarcopenia is a predictive factor for both long-term and short-term outcomes in gastrointestinal oncology patients: a systematic review and meta-analysis. Cancer Imaging. 2019;19(1):82. Su H, Ruan J, Chen T, et al. CT-assessed Sarcopenia is a predictive factor for both long-term and short-term outcomes in gastrointestinal oncology patients: a systematic review and meta-analysis. Cancer Imaging. 2019;19(1):82.
32.
go back to reference Nishigori T, Okabe H, Tanaka E, et al. Sarcopenia as a predictor of pulmonary complications after esophagectomy for thoracic esophageal cancer. J Surg Oncol. 2016;113(6):678–84. Nishigori T, Okabe H, Tanaka E, et al. Sarcopenia as a predictor of pulmonary complications after esophagectomy for thoracic esophageal cancer. J Surg Oncol. 2016;113(6):678–84.
33.
go back to reference Mafune T, Mikami S, Otsubo T, et al. An investigation of factors related to food intake ability and swallowing difficulty after surgery for thoracic esophageal cancer. Dysphagia. 2019;34(4):592–9. Mafune T, Mikami S, Otsubo T, et al. An investigation of factors related to food intake ability and swallowing difficulty after surgery for thoracic esophageal cancer. Dysphagia. 2019;34(4):592–9.
34.
go back to reference Donohoe CL, Healy LA, Fanning M, et al. Impact of supplemental home enteral feeding postesophagectomy on nutrition, body composition, quality of life, and patient satisfaction. Dis Esophagus. 2017;30(9):1–9. Donohoe CL, Healy LA, Fanning M, et al. Impact of supplemental home enteral feeding postesophagectomy on nutrition, body composition, quality of life, and patient satisfaction. Dis Esophagus. 2017;30(9):1–9.
35.
go back to reference Okada G, Momoki C, Habu D, et al. Effect of postoperative oral intake on prognosis for esophageal cancer. Nutrients. 2019;11(6):1338. Okada G, Momoki C, Habu D, et al. Effect of postoperative oral intake on prognosis for esophageal cancer. Nutrients. 2019;11(6):1338.
36.
go back to reference Kumai Y, Samejima Y, Watanabe M, et al. Videofluoroscopic evaluation of pharyngeal swallowing dysfunction after esophagectomy with three-field lymph node dissection. Eur Arch Otorhinolaryngol. 2017;274(1):321–6. Kumai Y, Samejima Y, Watanabe M, et al. Videofluoroscopic evaluation of pharyngeal swallowing dysfunction after esophagectomy with three-field lymph node dissection. Eur Arch Otorhinolaryngol. 2017;274(1):321–6.
38.
go back to reference Miyamoto M, Kobayashi Y, Miyata E, et al. Residual recurrent nerve paralysis after esophagectomy is associated with preoperative lower serum albumin. Dysphagia. 2017;32(4):520–5. Miyamoto M, Kobayashi Y, Miyata E, et al. Residual recurrent nerve paralysis after esophagectomy is associated with preoperative lower serum albumin. Dysphagia. 2017;32(4):520–5.
Metadata
Title
Effect of Postoperative Oral Intake Status on Sarcopenia Six Months After Esophageal Cancer Surgery
Authors
Nanako Hijikata
Aiko Ishikawa
Satoru Matsuda
Michiyuki Kawakami
Kaori Muraoka
Makiko Ando
Shuhei Mayanagi
Tomoyuki Irino
Hirofumi Kawakubo
Yuko Kitagawa
Tetsuya Tsuji
Publication date
18-06-2022
Publisher
Springer US
Published in
Dysphagia / Issue 1/2023
Print ISSN: 0179-051X
Electronic ISSN: 1432-0460
DOI
https://doi.org/10.1007/s00455-022-10471-z

Other articles of this Issue 1/2023

Dysphagia 1/2023 Go to the issue